FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.
Location: Switzerland, Basel-City, Basel
Member count: 11-50
Total raised: $12.111493M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 08.11.2022 | M Ventures | m-ventures... |
| - | Omega Fund... | omegafunds... |
| - | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 23.04.2020 | Seed | $12.111493... | Omega Fund... | m-ventures... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 22.04.2021 | Senior lea... | Jörg Bode, a financial expert ... | People | - | startuptic... |
| 22.04.2021 | Senior lea... | Jörg Bode, a financial exper... | Background... | - | startuptic... |
| 22.04.2020 | FoRx Thera... | FoRx Therapeutics, a Basel, Sw... | Switzerlan... | - | finsmes.co... |
| 22.04.2020 | Basel-base... | Established in October 2019 in... | Investment... | - | startuptic... |
| 22.04.2020 | Basel-base... | Established in October 2019 ... | Financing | - | startuptic... |
| - | FoRx Thera... | First Company to Develop a Pip... | - | - | m-ventures... |